Participation in Faecal Occult Blood Screening for Colorectal Cancer in a Well Defined French Population: Results of Five Screening Rounds from 1988 to 1996

Tazi, M. A.; Faivre, Jean; F, Dassonville; J, Lamour; Milan, Chantal; Durand, Gérard

doi:10.1177/096914139700400307

Cited by 70 publications

(44 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It also represents the first such data internationally for a program that is based on VC. The adjusted overall participation rate in our program of 28.4% should be placed in context with Australian or French community-based screening programs of similar design using faecal occult blood testing (23-34% participation) 10,11 or flexible sigmoidoscopy (23%). 12 None of these studies had general practitioner involvement in recruitment and none had the publicity campaigns of mammography or cervical screening, which in Australia are accompanied by participation rates of 54% and 64% in the target age ranges 50-69 and 20-69 years respectively.…”

Section: Discussionmentioning

confidence: 99%

Influences on participation in a community‐based colorectal neoplasia screening program by virtual colonoscopy in Australia

Forbes

Fritschi

Mendelson

et al. 2004

Australian and New Zealand Journal of Public Health

View full text Add to dashboard Cite

Objective: To determine the effect of certain personal and health behaviour characteristics on participation in a community-based colorectal neoplasia (CRN) screening program using virtual colonoscopy. Methods: The study population comprised randomly selected subjects from the State electoral roll; screening by virtual colonoscopy was offered through letter of invitation. For non-responders, a further invitation was sent a month later. Nonresponse after a further month led to subjects being considered non-participants. Non-participants were contacted by letter to complete a structured questionnaire; participants completed a similar questionnaire immediately after their screening virtual colonoscopy. Results: Discussing the invitation to screening with someone else increased the likelihood of participation by 63% (prevalence ratio 1.63, 95% CI 1.38-1.93); knowing someone with cancer increased the likelihood of participation by 23% (PR 1.23, 95% CI 1.07-1.42). Among participants who discussed screening with another individual, the spouse was the most common (71%). Subjects who were single were less likely to participate (PR 0.79, 95% CI 0.67-0.94). The strongest reported influence for participation was information provided in the letter of invitation (29.8%). The most common reasons for non-participation were lack of time and perceived good health. Conclusions and Implications:This study suggests that a simple strategy to facilitate participation is to encourage subjects to discuss screening with others; further, to recognise that this may be most difficult for those who are single. Information provided to subjects prior to screening positively contributes to participation.

show abstract

Section: Discussionmentioning

confidence: 99%

Influences on participation in a community‐based colorectal neoplasia screening program by virtual colonoscopy in Australia

Forbes

Fritschi

Mendelson

et al. 2004

Australian and New Zealand Journal of Public Health

View full text Add to dashboard Cite

show abstract

“…The design of the study has been reported previously (Tazi et al, 1997). Briefly, faecal occult blood screening using the Hemoccult II test was offered to all the residents of 12 well-defined administrative areas of Burgundy (France) who were born between 1914 and 1943.…”

Section: Study Settingmentioning

confidence: 99%

“…It is not known whether the results of these studies can be extrapolated to other countries (such as France) where the prognosis of CRC in the general population is better than in Denmark or England (Berrino et al, 1995). In this situation, the reduction in CRC mortality due to FOBT might be lower and a population-based controlled study of the question is under way in Burgundy (Tazi et al, 1997). The final results will be available within 2 years.…”

Section: Introductionmentioning

confidence: 99%

Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study

et al. 1999

Self Cite

View full text Add to dashboard Cite

SummaryTo estimate the efficacy of screening on colorectal cancer mortality, a population-based case-control study was conducted in welldefined areas of Burgundy (France). Screening by faecal occult blood test prior to diagnosis in cases born between 1914 and 1943 and who died of colorectal cancer diagnosed in 1988-94 was compared with screening in controls matched with the case for age, sex and place of residence. Cases were less likely to have been screened than controls, with an odds ratio (OR) of 0.67 [95% confidence interval (CI) 0.48-0.94]. The negative overall association did not differ by gender or by anatomical location. The odds ratio of death from colorectal cancer was 0.64 (95% CI 0.46-0.91) for those screened within 3 years of case diagnosis compared with those not screened. It was 1.14 (95% CI 0.50-2.63) for those screened more than 3 years before case diagnosis. There was a negative association between the risk of death from colorectal cancer and the number of participations in the screening campaigns. The inverse association between screening for faecal occult blood and fatal colorectal cancer suggests that screening can reduce colorectal cancer mortality. This report further supports recommendations for population-based mass screening with faecal occult blood test.

show abstract

“…The study design has been described previously (Tazi et al, 1997). All residents (n = 45 603) of 12 administrative districts of the department of Saône-et-Loire (Burgundy, France), born between 1914 and1943 (aged 45-74 years), were invited to participate in a mass screening programme for colorectal cancer.…”

Section: Methodsmentioning

confidence: 99%

Estimation of screening test (Hemoccult®) sensitivity in colorectal cancer mass screening

Jouve

Remontet²,

Dancourt

et al. 2001

Br J Cancer

Self Cite

View full text Add to dashboard Cite

Summary 3 controlled cohorts of mass-screening for colorectal cancer using a biennial faecal occult blood (HemoccultII ® ) test on well-defined European populations have demonstrated a 14% to 18% reduction in specific mortality. We aimed to estimate the sensitivity (S) of this HemoccultII ® test and and also mean sojourn time (MST) from French colorectal mass-screening programme data. 6 biennial screening rounds were performed from 1988 to 1998 in 45 603 individuals aged 45-74 years in Saône-et-Loire (Burgundy, France). The prevalent/incidence ratio was calculated in order to obtain a direct estimate of the product S.MST. The analysis of the proportional incidence and its modelling was used to derive an indirect estimate of S and MST. The product S.MST was higher for males than females and higher for left colon than either the right colon or rectum. The analysis of the proportional incidence confirmed the result for subsites but no other significant differences were found. The sensitivity was estimated at 0.57 and the MST at 2.56 years. This study confirms that the sensitivity of the Hemoccult test is relatively low and that the relatively short sojourn time is in favour of annual screening.

show abstract

Participation in Faecal Occult Blood Screening for Colorectal Cancer in a Well Defined French Population: Results of Five Screening Rounds from 1988 to 1996

Abstract: In France, a participation rate of over 50% can be achieved in colorectal cancer screening by means of a faecal occult blood test. To achieve this, primary care physicians have to play an active part in the programme and the test must be mailed to non-consultants.

Cited by 70 publications

References 14 publications

Influences on participation in a community‐based colorectal neoplasia screening program by virtual colonoscopy in Australia

Influences on participation in a community‐based colorectal neoplasia screening program by virtual colonoscopy in Australia

Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study

Estimation of screening test (Hemoccult®) sensitivity in colorectal cancer mass screening

Contact Info

Product

Resources

About